Literature DB >> 35194332

Doris Wilflingseder1, Wilfried Posch1.   

Abstract

Excessive inflammation triggered by a hitherto undescribed mechanism is a hallmark of severe SARS-CoV-2 infection and is associated with enhanced pathogenicity and mortality. Complement hyper activation promotes lung injury and was observed in patients suffering from MERS-CoV, SARS-CoV-1 and SARS-CoV-2 infections. To evaluate the very first interactions of SARS-CoV-2 patient isolates with human epithelial tissues, 3D models of the human respiratory tract as well as lung organoids are highly suitable. © Die Autorinnen und Autoren 2022.

Entities:  

Year:  2022        PMID: 35194332      PMCID: PMC8853259          DOI: 10.1007/s12268-022-1712-y

Source DB:  PubMed          Journal:  Biospektrum (Heidelb)        ISSN: 0947-0867


  14 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.

Authors:  Hongmei Gu; Amanda J Fisher; Elizabeth A Mickler; Frank Duerson; Oscar W Cummings; Marc Peters-Golden; Homer L Twigg; Trent M Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

3.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 4.  COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.

Authors:  Giuseppe Magro
Journal:  Virus Res       Date:  2020-06-20       Impact factor: 3.303

5.  Turning the World Upside-Down in Cellulose for Improved Culturing and Imaging of Respiratory Challenges within a Human 3D Model.

Authors:  Viktoria Zaderer; Martin Hermann; Cornelia Lass-Flörl; Wilfried Posch; Doris Wilflingseder
Journal:  Cells       Date:  2019-10-21       Impact factor: 6.600

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

8.  C5aR inhibition of non-immune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia.

Authors:  Wilfried Posch; Jonathan Vosper; Asma Noureen; Viktoria Zaderer; Christina Witting; Giulia Bertacchi; Ronald Gstir; Przemyslaw A Filipek; Günther K Bonn; Lukas A Huber; Rosa Bellmann-Weiler; Cornelia Lass-Flörl; Doris Wilflingseder
Journal:  J Allergy Clin Immunol       Date:  2021-04-11       Impact factor: 10.793

9.  ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.

Authors:  W Posch; J Vosper; V Zaderer; A Noureen; S Constant; R Bellmann-Weiler; C Lass-Flörl; D Wilflingseder
Journal:  mBio       Date:  2021-04-27       Impact factor: 7.867

10.  Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections.

Authors:  P Chandorkar; W Posch; V Zaderer; M Blatzer; M Steger; C G Ammann; U Binder; M Hermann; P Hörtnagl; C Lass-Flörl; D Wilflingseder
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.